drugset / Trial / NCT00488644
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
NaSingle-groupOpen-labelTreatment
Summary
Primary Objectives: 1. Assess whether combined treatment with Levothyroxine and Liothyronine improves learning and memory. 2. Explore the relationship between T3 treatment and other domains of cognitive function, quality of life, and mood.
Timeline
- Start
- 2006-02
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levothyroxine | Other / unclassified | 75 ug | Oral |
| Subject | Liothyronine | Small molecule | 15 ug | Oral |